vs
GLAUKOS Corp(GKOS)与MONARCH CASINO & RESORT INC(MCRI)财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是MONARCH CASINO & RESORT INC的1.0倍($143.1M vs $136.6M),MONARCH CASINO & RESORT INC净利率更高(20.2% vs -93.4%,领先113.6%),GLAUKOS Corp同比增速更快(35.7% vs 8.9%),过去两年GLAUKOS Corp的营收复合增速更高(29.3% vs 3.2%)
Glaukos Corp是一家专注于眼科领域的医疗科技企业,开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品,主要市场覆盖北美、欧洲及亚太地区,为全球医院、眼科诊所及患者提供服务。
君主赌场度假村集团是美国知名博彩度假企业,旗下运营位于内华达州里诺的亚特兰蒂斯赌场度假水疗中心。该物业设有三座酒店塔楼,共824间客房及套房,博彩区面积达64814平方英尺,是里诺当地盈利水平领先、定位高端的度假目的地,累计已投入近1.5亿美元用于设施升级。
GKOS vs MCRI — 直观对比
营收规模更大
GKOS
是对方的1.0倍
$136.6M
营收增速更快
GKOS
高出26.8%
8.9%
净利率更高
MCRI
高出113.6%
-93.4%
两年增速更快
GKOS
近两年复合增速
3.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $143.1M | $136.6M |
| 净利润 | $-133.7M | $27.6M |
| 毛利率 | -1.1% | — |
| 营业利润率 | -97.7% | 25.6% |
| 净利率 | -93.4% | 20.2% |
| 营收同比 | 35.7% | 8.9% |
| 净利润同比 | -298.0% | 38.9% |
| 每股收益(稀释后) | $-2.34 | $1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GKOS
MCRI
| Q1 26 | — | $136.6M | ||
| Q4 25 | $143.1M | $140.0M | ||
| Q3 25 | $133.5M | $142.8M | ||
| Q2 25 | $124.1M | $136.9M | ||
| Q1 25 | $106.7M | $125.4M | ||
| Q4 24 | $105.5M | $134.5M | ||
| Q3 24 | $96.7M | $137.9M | ||
| Q2 24 | $95.7M | $128.1M |
净利润
GKOS
MCRI
| Q1 26 | — | $27.6M | ||
| Q4 25 | $-133.7M | $22.9M | ||
| Q3 25 | $-16.2M | $31.6M | ||
| Q2 25 | $-19.7M | $27.0M | ||
| Q1 25 | $-18.1M | $19.9M | ||
| Q4 24 | $-33.6M | $4.2M | ||
| Q3 24 | $-21.4M | $27.6M | ||
| Q2 24 | $-50.5M | $22.7M |
毛利率
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | -1.1% | 20.8% | ||
| Q3 25 | 78.4% | 26.7% | ||
| Q2 25 | 78.3% | 25.5% | ||
| Q1 25 | 77.2% | 20.2% | ||
| Q4 24 | 72.9% | 2.9% | ||
| Q3 24 | 76.6% | 25.6% | ||
| Q2 24 | 76.4% | 23.0% |
营业利润率
GKOS
MCRI
| Q1 26 | — | 25.6% | ||
| Q4 25 | -97.7% | 21.3% | ||
| Q3 25 | -12.3% | 27.1% | ||
| Q2 25 | -18.3% | 25.8% | ||
| Q1 25 | -19.4% | 20.4% | ||
| Q4 24 | -27.2% | 3.1% | ||
| Q3 24 | -25.5% | 25.5% | ||
| Q2 24 | -31.3% | 22.9% |
净利率
GKOS
MCRI
| Q1 26 | — | 20.2% | ||
| Q4 25 | -93.4% | 16.4% | ||
| Q3 25 | -12.2% | 22.1% | ||
| Q2 25 | -15.8% | 19.7% | ||
| Q1 25 | -17.0% | 15.8% | ||
| Q4 24 | -31.8% | 3.1% | ||
| Q3 24 | -22.1% | 20.0% | ||
| Q2 24 | -52.8% | 17.7% |
每股收益(稀释后)
GKOS
MCRI
| Q1 26 | — | $1.52 | ||
| Q4 25 | $-2.34 | $1.25 | ||
| Q3 25 | $-0.28 | $1.69 | ||
| Q2 25 | $-0.34 | $1.44 | ||
| Q1 25 | $-0.32 | $1.05 | ||
| Q4 24 | $-0.56 | $0.25 | ||
| Q3 24 | $-0.39 | $1.47 | ||
| Q2 24 | $-1.00 | $1.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.8M | $120.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $656.2M | $549.8M |
| 总资产 | $893.5M | $725.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
GKOS
MCRI
| Q1 26 | — | $120.1M | ||
| Q4 25 | $90.8M | — | ||
| Q3 25 | $98.2M | — | ||
| Q2 25 | $100.8M | — | ||
| Q1 25 | $114.3M | — | ||
| Q4 24 | $169.6M | — | ||
| Q3 24 | $100.1M | — | ||
| Q2 24 | $68.1M | — |
股东权益
GKOS
MCRI
| Q1 26 | — | $549.8M | ||
| Q4 25 | $656.2M | $537.7M | ||
| Q3 25 | $769.5M | $558.4M | ||
| Q2 25 | $765.1M | $539.2M | ||
| Q1 25 | $764.0M | $535.6M | ||
| Q4 24 | $766.9M | $517.7M | ||
| Q3 24 | $668.5M | $513.3M | ||
| Q2 24 | $665.2M | $498.4M |
总资产
GKOS
MCRI
| Q1 26 | — | $725.2M | ||
| Q4 25 | $893.5M | $712.8M | ||
| Q3 25 | $999.4M | $725.4M | ||
| Q2 25 | $987.0M | $705.8M | ||
| Q1 25 | $966.2M | $712.1M | ||
| Q4 24 | $974.8M | $691.6M | ||
| Q3 24 | $926.5M | $671.1M | ||
| Q2 24 | $919.7M | $672.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $6.8M | — |
| 自由现金流经营现金流 - 资本支出 | $3.9M | — |
| 自由现金流率自由现金流/营收 | 2.7% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-22.5M | — |
8季度趋势,按日历期对齐
经营现金流
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | $6.8M | $38.1M | ||
| Q3 25 | $-10.1M | $56.0M | ||
| Q2 25 | $7.0M | $34.1M | ||
| Q1 25 | $-18.5M | $36.5M | ||
| Q4 24 | $507.0K | $37.8M | ||
| Q3 24 | $-9.6M | $40.3M | ||
| Q2 24 | $-18.4M | $24.3M |
自由现金流
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | $3.9M | $32.2M | ||
| Q3 25 | $-11.7M | $53.5M | ||
| Q2 25 | $5.8M | $26.0M | ||
| Q1 25 | $-20.5M | $16.6M | ||
| Q4 24 | $-1.2M | $26.2M | ||
| Q3 24 | $-11.0M | $35.4M | ||
| Q2 24 | $-20.5M | $11.0M |
自由现金流率
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 23.0% | ||
| Q3 25 | -8.8% | 37.5% | ||
| Q2 25 | 4.7% | 19.0% | ||
| Q1 25 | -19.2% | 13.3% | ||
| Q4 24 | -1.2% | 19.5% | ||
| Q3 24 | -11.4% | 25.7% | ||
| Q2 24 | -21.4% | 8.5% |
资本支出强度
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 4.2% | ||
| Q3 25 | 1.2% | 1.7% | ||
| Q2 25 | 0.9% | 5.9% | ||
| Q1 25 | 1.8% | 15.8% | ||
| Q4 24 | 1.6% | 8.6% | ||
| Q3 24 | 1.5% | 3.6% | ||
| Q2 24 | 2.2% | 10.4% |
现金转化率
GKOS
MCRI
| Q1 26 | — | — | ||
| Q4 25 | — | 1.66× | ||
| Q3 25 | — | 1.77× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | 8.98× | ||
| Q3 24 | — | 1.46× | ||
| Q2 24 | — | 1.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
| Glaucoma | $86.4M | 60% |
| Other | $35.1M | 25% |
| Corneal Health | $21.6M | 15% |
MCRI
| Casino | $79.7M | 58% |
| Food and beverage | $31.7M | 23% |
| Hotel | $19.0M | 14% |
| Other | $6.1M | 5% |